The Cell Therapy Partnerships & Strategy team brings together experts working at the forefront of clinical development to help shape AstraZeneca’s next generation of cell therapy innovation. By engaging critical external stakeholders, integrating leading scientific perspectives, and connecting external expertise with our research and development priorities, we accelerate meaningful progress across the portfolio.
As the Cell Therapy External Science Engagement & Strategy Director, you will lead the development and execution of external scientific engagement, strategic partnership, Externally Sponsored Collaborative Research, and medical congress strategies across AstraZeneca’s cell therapy portfolio. You will cultivate academic and scientific collaborations that accelerate clinical trial delivery, generate actionable insights, and strengthen AstraZeneca’s leadership within the evolving cell therapy ecosystem.
Operating at the intersection of strategy and execution, you will translate R&D priorities into coordinated, insight-led engagement plans with clear objectives, measurable outcomes, and robust governance. You will collaborate across Clinical Development, Translational Science, Medical Affairs, Regulatory, Clinical Operations, and other enterprise functions to connect external perspectives with decisions that advance our programs and benefit patients.
This is an opportunity to shape how AstraZeneca engages with leading scientists, investigators, academic institutions, professional societies, and cell therapy centers across hematology, autoimmune diseases, rare diseases, and neurology.
You will influence scientific and clinical development strategy through External Scientific Panels, Cell Therapy Science Committees, academic collaborations, Investigator-Initiated Trials, strategic-site partnerships, and priority medical congresses. Your work will help translate emerging science and external insight into stronger study designs, evidence-generation plans, operational improvements, and portfolio decisions.